Stent thrombosis with drug-eluting and bare-metal stents Reply

被引：0
|
作者：
Palmerini, Tullio [3 ]
Zoccai, Giuseppe Biondi [4 ]
Della Riva, Diego [3 ]
Stone, Gregg W. [1 ,2 ]
机构：
[1] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY 10032 USA
[2] Cardiovasc Res Fdn, New York, NY 10032 USA
[3] Policlin S Orsola, Dipartimento Cardiovasc, Bologna, Italy
[4] Univ Roma La Sapienza, Dept Medicosurg Sci & Biotechnol, Latina, Italy
来源：
LANCET | 2012年 / 380卷 / 9842期
关键词：
INTERVENTIONS;
D O I：
10.1016/S0140-6736(12)61366-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：646 / 647
页数：2
相关论文
共 50 条
  • [31] Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry)
    Yan, Bryan P.
    Duffy, Stephen J.
    Clark, David J.
    Lefkovits, Jeffery
    Warren, Roderic
    Gurvitch, Ronen
    Lew, Robert
    Sebastian, Martin
    Brennan, Angela
    Andrianopoulos, Nick
    Reid, Christopher M.
    Ajani, Andrew E.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (12): : 1716 - 1722
  • [32] Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis
    Almalla, Mohammad
    Pross, Verena
    Marx, Nikolaus
    Hoffmann, Rainer
    CORONARY ARTERY DISEASE, 2012, 23 (07) : 492 - 496
  • [33] Drug-eluting stents are as safe as bare-metal stents in patients with diabetes
    Nature Clinical Practice Cardiovascular Medicine, 2008, 5 (10): : 594 - 595
  • [34] Drug-eluting stents and bare-metal stents: assessment of professional practices
    Hadri, N.
    Federspiel, I.
    Bertrand, B.
    Schmitt, D.
    Calop, J.
    Foroni, L.
    Allenet, B.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (01) : 158 - 158
  • [35] Identification of independent risk factors for restenosis following bare-metal stent implantation: Role of bare-metal stents in the era of drug-eluting stents
    Park, Chang-Bum
    Park, Hoon-Ki
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 6 (03) : 840 - 846
  • [36] Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease
    Bonaa, K. H.
    Mannsverk, J.
    Wiseth, R.
    Aaberge, L.
    Myreng, Y.
    Nygard, O.
    Nilsen, D. W.
    Klow, N. -E.
    Uchto, M.
    Trovik, T.
    Bendz, B.
    Stavnes, S.
    Bjornerheim, R.
    Larsen, A. -I.
    Slette, M.
    Steigen, T.
    Jakobsen, O. J.
    Bleie, O.
    Fossum, E.
    Hanssen, T. A.
    Dahl-Eriksen, O.
    Njolstad, I.
    Rasmussen, K.
    Wilsgaard, T.
    Nordrehaug, J. E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (13): : 1242 - 1252
  • [37] Drug-eluting or bare-metal stents for acute myocardial infarction
    Mauri, Laura
    Silbaugh, Treacy S.
    Garg, Pallav
    Wolf, Robert E.
    Zelevinsky, Katya
    Lovett, Ann
    Varma, Manu R.
    Zhou, Zheng
    Normand, Sharon-Lise T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (13): : 1330 - 1342
  • [38] Drug-Eluting or Bare-Metal Stents in Large Coronary Arteries
    Aminian, Adel
    Lalmand, Jacques
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (12): : 1179 - 1180
  • [39] Efficacy of Drug-Eluting Balloon in Patients with Bare-Metal or Drug-Eluting Stent Restenosis
    Berta, Balazs
    Jambrik, Zoltan
    Kohar, Krisztina
    Szabo, Gyorgy
    Ruzsa, Zoltan
    Molnar, Levente
    Barczi, Gyorgy
    Geller, Laszlo
    Becker, David
    Merkely, Bela
    HELLENIC JOURNAL OF CARDIOLOGY, 2014, 55 (05) : 369 - 377
  • [40] Drug-Eluting versus Bare-Metal Stents: When and for Whom?
    Beyar, Rafael
    Nikolsky, Eugenia
    JOURNAL OF INVASIVE CARDIOLOGY, 2008, 20 (03): : 105 - 106
12345